Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)
Maravai Lifesciences Holdings' (MRVI) quarterly Dividends Paid - Common came in at -$78000.0 in Q4 2024, down 113.64% quarter-over-quarter from $572000.0 in Q2 2024.
Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024) Analysis & Trends
Maravai Lifesciences Holdings' Dividends Paid - Common history runs 5 years deep, the most recent figure standing at -$78000.0 for Q4 2024.
- On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to -$78000.0 in Q4 2024; TTM through Sep 2025 was $494000.0, a 13.64% decrease from a year earlier, with the FY2024 full-year figure at $494000.0, down 94.86% from the prior year.
- Dividends Paid - Common slipped to -$78000.0 in Q4 2024 per MRVI's latest filing, from $572000.0 in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $119.7 million in Q4 2020 and bottomed at -$78000.0 in Q4 2024.
- The 5-year median for Dividends Paid - Common is $30.9 million (2022), against an average of $33.1 million.
- Across the five-year window, Dividends Paid - Common soared 40961.48% in 2021 and sank 96.94% in 2023, its largest moves.
- Year by year, Dividends Paid - Common stood at $119.7 million in 2020, then fell by 8.1% to $110.0 million in 2021, then tumbled by 71.89% to $30.9 million in 2022, then sank by 95.78% to $1.3 million in 2023, then sank by 105.98% to -$78000.0 in 2024.
- Per Business Quant, the three latest MRVI Dividends Paid - Common figures stand at -$78000.0 (Q4 2024), $572000.0 (Q2 2024), and $1.3 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -78,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 8.30 Mn |
| Mar 31, 2023 | 8.30 Mn |
| Dec 31, 2022 | 30.92 Mn |
| Dec 31, 2022 | 30.92 Mn |
| Sep 30, 2022 | 36.81 Mn |
| Sep 30, 2022 | 36.81 Mn |
| Jun 30, 2022 | 42.59 Mn |
| Jun 30, 2022 | 42.59 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Mar 31, 2022 | 39.89 Mn |
| Dec 31, 2021 | 110.00 Mn |
| Dec 31, 2021 | 110.00 Mn |
| Sep 30, 2021 | 50.10 Mn |
| Sep 30, 2021 | 50.10 Mn |